[To what extent can prostaglandin synthesis inhibitors of the non-steroidal antirheumatic (NSAR) type modify the effect of ACE inhibitors?].
作者信息
Grote L
机构信息
Medizinische Poliklinik, Klinikum, Phillips-Universität, Marburg.
出版信息
Internist (Berl). 1995 Dec;36(12):1203-4.
PMID:8567229
Abstract
摘要
相似文献
1
[To what extent can prostaglandin synthesis inhibitors of the non-steroidal antirheumatic (NSAR) type modify the effect of ACE inhibitors?].
Internist (Berl). 1995 Dec;36(12):1203-4.
2
Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
Clin Pharmacol Ther. 1998 Jan;63(1):79-86. doi: 10.1016/S0009-9236(98)90123-0.
3
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?肾素-血管紧张素系统抑制对靶器官保护的作用：我们能否做得更好？
Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019.
4
5
6
[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].肾素口服抑制剂及其作为治疗高血压的治疗药物的潜在用途
Harefuah. 2008 Jun;147(6):536-42, 573.
7
8
9
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.以心血管终点为指标的高血压大型试验：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂的作用
Am Heart J. 2004 Nov;148(5):747-54. doi: 10.1016/j.ahj.2004.04.037.
10
[Hypertension 2007-2008].[高血压2007 - 2008年]
Med Klin (Munich). 2009 Aug;104(8):614-21. doi: 10.1007/s00063-009-1133-4. Epub 2009 Aug 23.
Zotero 插件